Marlborough

Boston Scientific has won regulatory clearance for what it says is the first disposable duodenoscope, a device inserted through the mouth so doctors can look into the small intestine.

Marlborough-based GE Healthcare Life Sciences has signed a research and development and distribution partnership with a Kentucky health software and equipment company with a goal of personalizing tissue regeneration.

A schizophrenia drug under development by Marlborough pharmaceutical firm Sunovion has been shown in a study to provide meaningful improvements to patients, the company said Thursday.

A sprawling, 173,000-square-foot Marlborough facility occupied by medical device company Hologic since before the company moved its headquarters to the city has sold for nearly $17.2 million.

CoStar Group reports Marlborough and Fitchburg saw vacancies rise in the third quarter while rents dipped.

In Framingham, the influx of Brazilians has been particularly crucial to the revival of a former mill town going through hard times.

When Central Massachusetts companies look to fill software, programming or research jobs, they’re increasingly looking to foreign labor under an immigrant work program called H-1B.

Quest Diagnostics has acquired the lab services of Boston Clinical Laboratories of Waltham.

Sunovion Pharmaceuticals of Marlborough is seeking for the second time U.S. Food and Drug Administration approval for a new drug aimed at helping Parkinson's disease patients.

Phio Pharmaceuticals Corp. has closed its previously announced public offering of 10 million shares of its common stock at 10 cents per share.